^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
1 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
NR 283 Pathophysiology Test Question Bank
/ NR283 Test Question Bank / NR 283 Patho
Chamberlain NR283 Test Question Bank
(Exam 1, Exam 2, Exam 3, Final Exam)
1. Which of the following areas lacks blood vessels and nerves?
a. Epidermis
b. Dermis
c. Subcutaneous tissue
d. Fatty tissue
ANS: A REF: 142
2. What is a raised, thin-walled lesion containing clear fluid called?
a. Papule
b. Pustule
c. Vesicle
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
1 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
,^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
2 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
d. Macule
ANS: C REF: 143
3. Which of the following is a common effect of a type I hypersensitivity response to
ingestedsubstances?
a. Contact dermatitis
b. Urticarial
c. Discoid lupus erythematosus
d. Psoriasis
ANS: B REF: 145
4. What change occurs in the skin with psoriasis?
a. Recurrent hypersensitivity reactions
b. Autoimmune response
c. Increased mitosis and shedding of epithelium
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
2 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
,^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
3 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
d. Basal cell degeneration
ANS: C REF: 147
5. Which of the following best describes the typical lesion of psoriasis?
a. Purplish papules that can erode and become open ulcers
b. Firm, raised pruritic nodules that can become cancerous
c. Moist, red vesicles, which develop into bleeding ulcers
d. Begins as a red papule and develops into silvery plaques
ANS: D REF: 147
6. Why do secondary infections frequently develop in pruritic lesions?
a. Loss of protective sebum
b. Entry of resident flora while scratching the lesion
c. Blockage of sebaceous glands
d. Increased sweat production
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
3 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
,^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
4 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
Stuvia.com - The Marketplace to Buy and Sell your Study Material
ANS: B REF: 148
7. Which disease is considered an autoimmune disorder?
a. Pemphigus
b. Erysipelas
c. Contact dermatitis
d. Scleroderma
ANS: A REF: 147
8. Which of the following skin lesions are usually caused by Staphylococcus aureus?
a. Furuncles
b. Verrucae
c. Scabies
d. Tinea
ANS: A REF: 148
9. Which of the following statements applies to impetigo?
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
4 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
(!*NR 283##*&Page
Pathophysiology
1 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
NR 283 Pathophysiology Test Question Bank
/ NR283 Test Question Bank / NR 283 Patho
Chamberlain NR283 Test Question Bank
(Exam 1, Exam 2, Exam 3, Final Exam)
1. Which of the following areas lacks blood vessels and nerves?
a. Epidermis
b. Dermis
c. Subcutaneous tissue
d. Fatty tissue
ANS: A REF: 142
2. What is a raised, thin-walled lesion containing clear fluid called?
a. Papule
b. Pustule
c. Vesicle
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
1 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
,^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
2 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
d. Macule
ANS: C REF: 143
3. Which of the following is a common effect of a type I hypersensitivity response to
ingestedsubstances?
a. Contact dermatitis
b. Urticarial
c. Discoid lupus erythematosus
d. Psoriasis
ANS: B REF: 145
4. What change occurs in the skin with psoriasis?
a. Recurrent hypersensitivity reactions
b. Autoimmune response
c. Increased mitosis and shedding of epithelium
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
2 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
,^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
3 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
d. Basal cell degeneration
ANS: C REF: 147
5. Which of the following best describes the typical lesion of psoriasis?
a. Purplish papules that can erode and become open ulcers
b. Firm, raised pruritic nodules that can become cancerous
c. Moist, red vesicles, which develop into bleeding ulcers
d. Begins as a red papule and develops into silvery plaques
ANS: D REF: 147
6. Why do secondary infections frequently develop in pruritic lesions?
a. Loss of protective sebum
b. Entry of resident flora while scratching the lesion
c. Blockage of sebaceous glands
d. Increased sweat production
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
3 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
,^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283##*&Page
Pathophysiology
4 of 35110/16/2026,
Test Question5:42:03
Bank_removed10/16/2026,
283
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question283
Bank_rem
Patho
Stuvia.com - The Marketplace to Buy and Sell your Study Material
ANS: B REF: 148
7. Which disease is considered an autoimmune disorder?
a. Pemphigus
b. Erysipelas
c. Contact dermatitis
d. Scleroderma
ANS: A REF: 147
8. Which of the following skin lesions are usually caused by Staphylococcus aureus?
a. Furuncles
b. Verrucae
c. Scabies
d. Tinea
ANS: A REF: 148
9. Which of the following statements applies to impetigo?
^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
(!*NR 283Page
Pathophysiology
4 of 35110/16/2026,
Test Question
5:42:03Bank_removed10/16/2026,
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*NR
283 Pathophysiology Test
5:42:03
Question
AM*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!*&$!*#)(!*##(*0NR
Bank_removed.pdf*&!#%#&&!%%#^#^&^!#&*^&^*#!(FG*T!^&*#*((*!#&()#_)#!
283 Pathophysiology Test Question Bank_remove
283 Patho
